2.5 mg retatrutide UK: New Triple-Agonist Weight Loss Injection Explained Weight loss drug retatrutide use

A landmark 2026 narrative review in Clinical Obesity (Urbina et al.) spanning 480,825 adults found vitamin D deficiency in 13.6% of users by 12 months, iron depletion with 2630% lower ferritin, and more than 60% consuming below requirements for calcium and iron (PubMed)

Data availability The data that support the findings of this study are openly available in TCGA database of PTCs utilizing the Firehouse web browser from the Broad Institute ( using TIMER2.0 ( a computational software for analyses of tumor immunologic, clinical, and genomic features 35

Other considerations include side effects (such as nausea or digestive upset) and cost

Intramuscular Melanotan-2 injection accelerates absorption kinetics beyond the subcutaneous depot design, causing higher peak plasma concentrations within 30-60 minutes instead of the 2-4 hour gradual release intended for subcutaneous administration